{"component": "definition", "props": {"groups": [{"samples": [{"hash": "g5TYfTvULRw", "uri": "/contracts/g5TYfTvULRw#collaboration-product", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 30.4072551727, "published": true}, {"hash": "idtJNVrIV8W", "uri": "/contracts/idtJNVrIV8W#collaboration-product", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 30.3305950165, "published": true}, {"hash": "dtcFeYHN9oB", "uri": "/contracts/dtcFeYHN9oB#collaboration-product", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 26.7878170013, "published": true}], "size": 50, "snippet": "means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.", "snippet_links": [{"key": "pharmaceutical-product", "type": "definition", "offset": [10, 32]}, {"key": "finished-form", "type": "definition", "offset": [36, 49]}, {"key": "collaboration-compound", "type": "definition", "offset": [66, 88]}, {"key": "in-combination", "type": "definition", "offset": [130, 144]}, {"key": "other-active-ingredients", "type": "clause", "offset": [162, 186]}], "hash": "cc86bca5a9ac879e09d405436164c10b", "id": 1}, {"samples": [{"hash": "1PRlwCf6H1w", "uri": "/contracts/1PRlwCf6H1w#collaboration-product", "label": "Master Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "jyCPZUGoLnP", "uri": "/contracts/jyCPZUGoLnP#collaboration-product", "label": "Master Collaboration Agreement (Prothena Corp PLC)", "score": 29.6242294312, "published": true}, {"hash": "8T8ysQBgaFY", "uri": "/contracts/8T8ysQBgaFY#collaboration-product", "label": "Master Collaboration Agreement (Prothena Corp PLC)", "score": 29.3504447937, "published": true}], "size": 15, "snippet": "means, on a Program-by-Program basis, any product that constitutes, incorporates, comprises or contains a Collaboration Candidate from such Program, whether or not as the sole active ingredient, and in all forms, presentations, and formulations (including manner of delivery and dosage). For clarity, different forms, formulations, presentations or dosage strengths of a given Collaboration Product that constitute, incorporate, comprise or contain the same Collaboration Candidate shall be considered the same Collaboration Product for purposes of this Agreement.", "snippet_links": [{"key": "collaboration-candidate", "type": "definition", "offset": [106, 129]}, {"key": "active-ingredient", "type": "definition", "offset": [176, 193]}, {"key": "manner-of-delivery", "type": "clause", "offset": [256, 274]}, {"key": "for-clarity", "type": "clause", "offset": [288, 299]}, {"key": "for-purposes-of-this-agreement", "type": "clause", "offset": [533, 563]}], "hash": "2eb50161e013610f87a3d41e932a8378", "id": 2}, {"samples": [{"hash": "iAP6vBQXNDS", "uri": "/contracts/iAP6vBQXNDS#collaboration-product", "label": "License and Collaboration Agreement (Regulus Therapeutics Inc.)", "score": 32.364818573, "published": true}, {"hash": "3qUkQUY5P8p", "uri": "/contracts/3qUkQUY5P8p#collaboration-product", "label": "License and Collaboration Agreement (Regulus Therapeutics Inc.)", "score": 23.6255989075, "published": true}, {"hash": "f0zJrW1oLsl", "uri": "/contracts/f0zJrW1oLsl#collaboration-product", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "size": 11, "snippet": "means any product that contains one or more Discovered RNAi Compound(s) as active ingredient(s).", "snippet_links": [], "hash": "8b923d68708dc8eb071e6f40d5c69de4", "id": 3}, {"samples": [{"hash": "42YbwpFWwnX", "uri": "/contracts/42YbwpFWwnX#collaboration-product", "label": "Joint Venture Agreement (Geron Corporation)", "score": 20.0, "published": true}, {"hash": "56xcrP54P2I", "uri": "/contracts/56xcrP54P2I#collaboration-product", "label": "Joint Venture Agreement (Geron Corp)", "score": 18.0, "published": true}], "size": 11, "snippet": "means any product that is described in, is claimed in, incorporates or contains any Collaboration Technology;", "snippet_links": [{"key": "collaboration-technology", "type": "clause", "offset": [84, 108]}], "hash": "bbe6a0317cf310f9a5222e7d3144fde5", "id": 4}, {"samples": [{"hash": "j857JvtfC3R", "uri": "/contracts/j857JvtfC3R#collaboration-product", "label": "Stock Purchase Agreement (Genvec Inc)", "score": 18.0, "published": true}, {"hash": "gyJZXhxy5ZY", "uri": "/contracts/gyJZXhxy5ZY#collaboration-product", "label": "Stock Purchase Agreement (Genvec Inc)", "score": 18.0, "published": true}, {"hash": "9UqObHCeWna", "uri": "/contracts/9UqObHCeWna#collaboration-product", "label": "Stock Purchase Agreement (Genvec Inc)", "score": 18.0, "published": true}], "size": 9, "snippet": "shall have the meaning ascribed thereto in the Collaboration Agreement.", "snippet_links": [{"key": "collaboration-agreement", "type": "clause", "offset": [47, 70]}], "hash": "c4c4bbe6945877c8a62b6be0353a953d", "id": 5}, {"samples": [{"hash": "gfHBeyP7aBK", "uri": "/contracts/gfHBeyP7aBK#collaboration-product", "label": "Commercialization Agreement (Genvec Inc)", "score": 18.0, "published": true}, {"hash": "3s5sbe9HZGp", "uri": "/contracts/3s5sbe9HZGp#collaboration-product", "label": "Commercialization Agreement (Genvec Inc)", "score": 18.0, "published": true}], "size": 8, "snippet": "means a Product Configuration developed in the Research Program intended for use in the Field which the Steering Committee has designated as such pursuant to Section 2.4 of the Collaboration Agreement.", "snippet_links": [{"key": "product-configuration", "type": "definition", "offset": [8, 29]}, {"key": "the-research-program", "type": "clause", "offset": [43, 63]}, {"key": "intended-for-use", "type": "definition", "offset": [64, 80]}, {"key": "in-the-field", "type": "clause", "offset": [81, 93]}, {"key": "the-steering-committee", "type": "definition", "offset": [100, 122]}, {"key": "section-24", "type": "definition", "offset": [158, 169]}, {"key": "collaboration-agreement", "type": "clause", "offset": [177, 200]}], "hash": "a6d9da0628ce783986df6524224ce0dc", "id": 6}, {"samples": [{"hash": "aLizOchfmFs", "uri": "/contracts/aLizOchfmFs#collaboration-product", "label": "Collaboration Agreement (Seattle Genetics Inc /Wa)", "score": 21.0, "published": true}, {"hash": "2xw54xwkX1x", "uri": "/contracts/2xw54xwkX1x#collaboration-product", "label": "Collaboration Agreement (Seattle Genetics Inc /Wa)", "score": 21.0, "published": true}, {"hash": "hkj5bJouWZG", "uri": "/contracts/hkj5bJouWZG#collaboration-product", "label": "Collaboration Agreement (Northwest Biotherapeutics Inc)", "score": 18.0, "published": true}], "size": 7, "snippet": "means any Antibody Product that contains a Collaboration Antibody.", "snippet_links": [{"key": "antibody-product", "type": "definition", "offset": [10, 26]}, {"key": "collaboration-antibody", "type": "definition", "offset": [43, 65]}], "hash": "edaae61da8de85f7c2f2d85ed7ae9bf9", "id": 7}, {"samples": [{"hash": "ckHlTIAohNn", "uri": "/contracts/ckHlTIAohNn#collaboration-product", "label": "Collaborative Research, Development and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "ktheGy8YynQ", "uri": "/contracts/ktheGy8YynQ#collaboration-product", "label": "Collaborative Research, Development and License Agreement (Curis Inc)", "score": 24.5934295654, "published": true}, {"hash": "byyRFVT1Nnq", "uri": "/contracts/byyRFVT1Nnq#collaboration-product", "label": "Collaborative Research, Development and License Agreement (Curis Inc)", "score": 21.8473644257, "published": true}], "size": 7, "snippet": "means (a) a Lead Product that is designated as a \u201cCollaboration Product\u201d pursuant to Section 3.2, or (b) a Compound that is designated as a \u201cCollaboration Product\u201d pursuant to Section 6.1(a).", "snippet_links": [{"key": "lead-product", "type": "definition", "offset": [12, 24]}, {"key": "section-32", "type": "definition", "offset": [85, 96]}], "hash": "995c036ae5892bfe884664dbbbd78d32", "id": 8}, {"samples": [{"hash": "fyyY1aCKvdq", "uri": "/contracts/fyyY1aCKvdq#collaboration-product", "label": "Collaboration Agreement (Voyager Therapeutics, Inc.)", "score": 26.8453121185, "published": true}, {"hash": "d4YNOZGiWoQ", "uri": "/contracts/d4YNOZGiWoQ#collaboration-product", "label": "Collaboration Agreement (Voyager Therapeutics, Inc.)", "score": 26.8398361206, "published": true}, {"hash": "6A88nyJpxXr", "uri": "/contracts/6A88nyJpxXr#collaboration-product", "label": "Collaboration Agreement (Voyager Therapeutics, Inc.)", "score": 26.7686519623, "published": true}], "size": 6, "snippet": "means any Split Territory Collaboration Product or SMA Collaboration Product; provided, however, that once an Option is exercised for a Collaboration Program, any Collaboration Product generated by or that is the subject of such Collaboration Program shall become a Licensed Product and shall no longer be a Collaboration Product.", "snippet_links": [{"key": "split-territory-collaboration-product", "type": "definition", "offset": [10, 47]}, {"key": "sma-collaboration-product", "type": "definition", "offset": [51, 76]}, {"key": "collaboration-program", "type": "definition", "offset": [136, 157]}, {"key": "subject-of", "type": "clause", "offset": [213, 223]}, {"key": "licensed-product", "type": "clause", "offset": [266, 282]}], "hash": "dfc8c770ee3635cfceeb7cb896e7e044", "id": 9}, {"samples": [{"hash": "iXFlrYpX8ED", "uri": "/contracts/iXFlrYpX8ED#collaboration-product", "label": "Collaboration Agreement (Biotech Spinco, Inc.)", "score": 21.0, "published": true}, {"hash": "aCHiyqOrIMW", "uri": "/contracts/aCHiyqOrIMW#collaboration-product", "label": "Collaboration Agreement (Facet Biotech Corp)", "score": 21.0, "published": true}, {"hash": "8eDFan9vtXQ", "uri": "/contracts/8eDFan9vtXQ#collaboration-product", "label": "Collaboration Agreement (Protein Design Labs Inc/De)", "score": 21.0, "published": true}], "size": 6, "snippet": "means a Product being jointly Developed and Commercialized by the Parties under this Agreement pursuant to a Development Plan or a Commercialization Plan. For the avoidance of doubt, a Collaboration Product shall not be a Royalty Product.", "snippet_links": [{"key": "jointly-developed", "type": "definition", "offset": [22, 39]}, {"key": "by-the-parties", "type": "clause", "offset": [59, 73]}, {"key": "this-agreement", "type": "clause", "offset": [80, 94]}, {"key": "pursuant-to-a", "type": "definition", "offset": [95, 108]}, {"key": "development-plan", "type": "clause", "offset": [109, 125]}, {"key": "commercialization-plan", "type": "clause", "offset": [131, 153]}, {"key": "for-the-avoidance-of-doubt", "type": "clause", "offset": [155, 181]}, {"key": "royalty-product", "type": "definition", "offset": [222, 237]}], "hash": "88b499f14503253aac53d2bf81627822", "id": 10}], "next_curs": "CmISXGoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj4LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIeY29sbGFib3JhdGlvbi1wcm9kdWN0IzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 383, "title": "Collaboration Product", "snippet": "means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.", "id": "collaboration-product", "examples": ["Neither Freenome nor any of its Affiliates has received any written notice or threat in writing from any Person (including any invitation to license) asserting or alleging that any Development, Manufacture or Commercialization of any <strong>Collaboration Product</strong> by Freenome or its Affiliates has infringed, misappropriated or otherwise violated, will infringe, misappropriate or otherwise violate, or currently infringes, misappropriates or otherwise violates, any intellectual property rights of such Person.", "For the avoidance of doubt, an MCED Product is not a <strong>Collaboration Product</strong>.", "Except as otherwise provided herein, the PMA Responsible Party will be responsible for all medical device reporting, correction and removal reporting and execution of Recalls associated with any <strong>Collaboration Product</strong>, and the PMA Responsible Party will be the primary point of contact for any communications to the FDA and other Governmental Authorities, the media and customers concerning the Recall.", "In the event that the Parties reasonably anticipate that First-Line FDA Approval for the first <strong>Collaboration Product</strong> will not occur within [***] days following the Antitrust Clearance Date, the Parties will confer with one another in good faith regarding re-filing of Required Filings.", "Each PMA Responsible Party will provide the other Party with a copy of all final Regulatory Submissions for which it is responsible, and related correspondence (e.g., requests for additional information from a relevant Regulatory Authority and responses thereto), communications or meeting minutes that involve a material discussion of a <strong>Collaboration Product</strong> promptly after submission to or receipt from the relevant Regulatory Authority.", "Each PMA Responsible Party will keep the other Party reasonably informed with respect to the progress of obtaining PMA Approval of any <strong>Collaboration Product</strong> for which it is responsible.", "Each Party, at its expense, will be responsible for the prompt review, evaluation, and documentation of all complaints relating to any <strong>Collaboration Product</strong> for which it is the PMA Responsible Party.", "The Parties will equally share the applicable costs incurred by a Party under this Section 9.4 (Patent Right Extensions) in furtherance of such filing in the Field in the Territory for such <strong>Collaboration Product</strong>.", "Each PMA Responsible Party will provide the other Party with an opportunity to review and comment on all Regulatory Submissions relating to a <strong>Collaboration Product</strong> in the Field in the Territory for which such PMA Responsible Party is responsible and will provide such other Party with copies of all Regulatory Submissions relating to such <strong>Collaboration Products</strong>, whether first submitted to FDA prior to, on or following the Effective Date.", "Exact will provide such cooperation as Freenome may reasonably request in connection with any Recall of any <strong>Collaboration Product</strong>."], "related": [["licensed-product", "Licensed Product", "Licensed Product"], ["collaboration-compound", "Collaboration Compound", "Collaboration Compound"], ["licensed-compound", "Licensed Compound", "Licensed Compound"], ["licensed-compounds", "Licensed Compounds", "Licensed Compounds"], ["hemp-product", "Hemp product", "Hemp product"]], "related_snippets": [], "updated": "2026-04-30T06:05:53+00:00"}, "json": true, "cursor": ""}}